Herbalife (NYSE:HLF - Get Free Report) is set to release its earnings data after the market closes on Wednesday, October 30th. Analysts expect Herbalife to post earnings of $0.19 per share for the quarter. Herbalife has set its FY 2024 guidance at EPS and its Q3 2024 guidance at EPS.Investors that are interested in registering for the company's conference call can do so using this link.
Herbalife (NYSE:HLF - Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.54 EPS for the quarter, topping analysts' consensus estimates of $0.43 by $0.11. The business had revenue of $1.28 billion during the quarter, compared to analysts' expectations of $1.33 billion. Herbalife had a net margin of 1.63% and a negative return on equity of 18.69%. The business's revenue was down 2.5% on a year-over-year basis. During the same period last year, the company posted $0.74 EPS. On average, analysts expect Herbalife to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Herbalife Price Performance
Shares of NYSE HLF traded up $0.17 during mid-day trading on Wednesday, hitting $6.98. 2,074,558 shares of the company's stock traded hands, compared to its average volume of 2,068,507. Herbalife has a 1 year low of $6.59 and a 1 year high of $15.66. The company's 50-day moving average is $7.49 and its two-hundred day moving average is $9.35. The company has a market capitalization of $697.78 million, a P/E ratio of 5.09, a PEG ratio of 0.27 and a beta of 1.19.
Insider Buying and Selling
In other Herbalife news, Director Juan Miguel Mendoza bought 10,000 shares of Herbalife stock in a transaction on Monday, September 9th. The shares were acquired at an average price of $7.11 per share, for a total transaction of $71,100.00. Following the completion of the purchase, the director now directly owns 120,000 shares in the company, valued at approximately $853,200. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.94% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
HLF has been the subject of several analyst reports. StockNews.com lowered Herbalife from a "buy" rating to a "hold" rating in a research note on Tuesday. B. Riley lifted their price objective on shares of Herbalife from $16.00 to $17.00 and gave the stock a "buy" rating in a research note on Thursday, August 1st. Finally, DA Davidson increased their target price on shares of Herbalife from $9.50 to $13.00 and gave the company a "neutral" rating in a research note on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, Herbalife presently has a consensus rating of "Hold" and a consensus target price of $12.40.
View Our Latest Report on HLF
Herbalife Company Profile
(
Get Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Further Reading
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.